Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949730/
https://www.ncbi.nlm.nih.gov/pubmed/20831812
http://dx.doi.org/10.1186/1757-2215-3-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949730/
https://www.ncbi.nlm.nih.gov/pubmed/20831812
http://dx.doi.org/10.1186/1757-2215-3-21

Ejemplares similares